IRIDEX PE Ratio 2010-2023 | IRIX
Current and historical p/e ratio for IRIDEX (IRIX) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IRIDEX PE ratio as of April 19, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| IRIDEX PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-04-19 |
2.87 |
|
0.00 |
| 2023-12-31 |
2.81 |
$-0.59 |
0.00 |
| 2023-09-30 |
2.54 |
$-0.48 |
0.00 |
| 2023-06-30 |
2.17 |
$-0.48 |
0.00 |
| 2023-03-31 |
2.03 |
$-0.45 |
0.00 |
| 2022-12-31 |
2.01 |
$-0.47 |
0.00 |
| 2022-09-30 |
2.41 |
$-0.55 |
0.00 |
| 2022-06-30 |
2.57 |
$-0.58 |
0.00 |
| 2022-03-31 |
4.63 |
$-0.35 |
0.00 |
| 2021-12-31 |
6.11 |
$-0.34 |
0.00 |
| 2021-09-30 |
7.66 |
$-0.20 |
0.00 |
| 2021-06-30 |
7.06 |
$-0.18 |
0.00 |
| 2021-03-31 |
6.75 |
$-0.47 |
0.00 |
| 2020-12-31 |
2.51 |
$-0.45 |
0.00 |
| 2020-09-30 |
1.96 |
$-0.55 |
0.00 |
| 2020-06-30 |
2.12 |
$-0.56 |
0.00 |
| 2020-03-31 |
1.59 |
$-0.54 |
0.00 |
| 2019-12-31 |
2.23 |
$-0.64 |
0.00 |
| 2019-09-30 |
1.85 |
$-0.74 |
0.00 |
| 2019-06-30 |
4.55 |
$-0.87 |
0.00 |
| 2019-03-31 |
4.56 |
$-0.97 |
0.00 |
| 2018-12-31 |
4.70 |
$-1.06 |
0.00 |
| 2018-09-30 |
6.35 |
$-1.29 |
0.00 |
| 2018-06-30 |
6.96 |
$-1.30 |
0.00 |
| 2018-03-31 |
5.72 |
$-1.26 |
0.00 |
| 2017-12-31 |
7.62 |
$-1.11 |
0.00 |
| 2017-09-30 |
9.37 |
$-1.71 |
0.00 |
| 2017-06-30 |
9.89 |
$-1.51 |
0.00 |
| 2017-03-31 |
11.87 |
$-1.30 |
0.00 |
| 2016-12-31 |
14.06 |
$-1.13 |
0.00 |
| 2016-09-30 |
14.49 |
$-0.05 |
0.00 |
| 2016-06-30 |
14.79 |
$0.06 |
246.50 |
| 2016-03-31 |
10.22 |
$0.02 |
511.00 |
| 2015-12-31 |
9.29 |
$0.03 |
309.67 |
| 2015-09-30 |
7.61 |
$0.85 |
8.95 |
| 2015-06-30 |
8.25 |
$0.86 |
9.59 |
| 2015-03-31 |
10.68 |
$0.96 |
11.13 |
| 2014-12-31 |
8.60 |
$0.99 |
8.69 |
| 2014-09-30 |
7.00 |
$0.17 |
41.18 |
| 2014-06-30 |
8.31 |
$0.17 |
48.88 |
| 2014-03-31 |
8.93 |
$0.18 |
49.61 |
| 2013-12-31 |
10.17 |
$0.22 |
46.23 |
| 2013-09-30 |
5.93 |
$0.20 |
29.65 |
| 2013-06-30 |
5.91 |
$0.07 |
84.43 |
| 2013-03-31 |
4.45 |
$0.06 |
74.17 |
| 2012-12-31 |
3.90 |
$0.15 |
26.00 |
| 2012-09-30 |
3.70 |
$0.21 |
17.62 |
| 2012-06-30 |
4.17 |
$0.32 |
13.03 |
| 2012-03-31 |
4.41 |
$0.38 |
11.61 |
| 2011-12-31 |
3.74 |
$0.26 |
14.38 |
| 2011-09-30 |
3.70 |
$0.26 |
14.23 |
| 2011-06-30 |
4.01 |
$0.32 |
12.53 |
| 2011-03-31 |
4.55 |
$0.31 |
14.68 |
| 2010-12-31 |
3.92 |
$0.30 |
13.07 |
| 2010-09-30 |
3.45 |
$0.28 |
12.32 |
| 2010-06-30 |
3.68 |
$0.26 |
14.15 |
| 2010-03-31 |
4.30 |
$0.31 |
13.87 |
| 2009-12-31 |
3.07 |
$0.29 |
10.59 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.049B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
